Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Löbel, Madlen ^a   Mooslechner, Agnes Anna ^a   Bauer, Sandra ^a   Günther, Sabrina ^a   Letsch, Anne ^a   Hanitsch, Leif G ^a   Grabowski, Patricia ^a   Meisel, Christian ^a   Volk, Hans Dieter ^a   Scheibenbogen, Carmen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic fatigue syndrome; HPA axis; Immunoglobulins

Indexed keywords

CATECHOL METHYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G3; METHIONINE; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR RECEPTOR; IMMUNOGLOBULIN G; TACROLIMUS BINDING PROTEIN 5;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DYSREGULATION; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; BLOOD; CASE CONTROL STUDY; DISEASE PREDISPOSITION; GENETICS; METABOLISM; MICROBIOLOGY;

CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DISEASE SUSCEPTIBILITY; FATIGUE SYNDROME, CHRONIC; HUMANS; HYDROCORTISONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; METHIONINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TACROLIMUS BINDING PROTEINS;

EID: 84939144446     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0628-4     Document Type: Article

References (47)

1. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T et al (2011) Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 270:327-338
2. Faulkner S, Smith A (2008) A longitudinal study of the relationship between psychological distress and recurrence of upper respiratory tract infections in chronic fatigue syndrome. Br J Health Psychol 13:177-186
3. Lattie EG, Antoni MH, Fletcher MA, Penedo F, Czaja S, Lopez C et al (2012) Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome. Brain Behav Immun 26:849-858
4. Gur A, Oktayoglu P (2008) Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des 14:1274-1294
5. Ocon AJ (2013) Caught in the thickness of brain fog: exploring the cognitive symptoms of chronic fatigue syndrome. Front Physiol 4:63
6. Meeus M, Roussel NA, Truijen S, Nijs J (2010) Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med 42:884-890
7. Tomas C, Newton J, Watson S (2013) A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci 2013:784520
8. Wyller VB, Godang K, Morkrid L, Saul JP, Thaulow E, Walloe L (2007) Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: relation to clinical symptoms. Pediatrics 120:e129-e137
9. Timmers HJ, Wieling W, Soetekouw PM, Bleijenberg G, Van Der Meer JW, Lenders JW (2002) Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clin Auton Res 12:273-280
10. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ (2000) Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 85:692-696
11. Strahler J, Fischer S, Nater UM, Ehlert U, Gaab J (2013) Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome. Biol Psychol 94:160-166
12. Eskandari F, Sternberg EM (2002) Neural-immune interactions in health and disease. Ann N Y Acad Sci 966:20-27
13. Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC et al (2008) Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med 70:298-305
14. Nijhof SL, Rutten JM, Uiterwaal CS, Bleijenberg G, Kimpen JL, Putte EM (2014) The role of hypocortisolism in chronic fatigue syndrome. Psychoneuroendocrinology 42:199-206
15. Jerjes WK, Taylor NF, Wood PJ, Cleare AJ (2007) Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 32:192-198
16. Christley Y, Duffy T, Everall IP, Martin CR (2013) The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma. Curr Psychiatry Rep 15:353
17. Papanicolaou DA, Amsterdam JD, Levine S, McCann SM, Moore RC, Newbrand CH et al (2004) Neuroendocrine aspects of chronic fatigue syndrome. Neuro Immuno Modulation 11:65-74
18. Skowera A, Cleare A, Blair D, Bevis L, Wessely SC, Peakman M (2004) High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 135:294-302
19. ter Wolbeek M, van Doornen LJ, Schedlowski M, Janssen OE, Kavelaars A, Heijnen CJ (2008) Glucocorticoid sensitivity of immune cells in severely fatigued adolescent girls: a longitudinal study. Psychoneuroendocrinology 33:375-385
20. Jiang JL, Qiu YH, Peng YP, Wang JJ (2006) Immunoregulatory role of endogenous catecholamines synthesized by immune cells. Sheng Li Xue Bao 58:309-317
21. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250
22. Sommerfeldt L, Portilla H, Jacobsen L, Gjerstad J, Wyller VB (2011) Polymorphisms of adrenergic cardiovascular control genes are associated with adolescent chronic fatigue syndrome. Acta Paediatr 100:293-298
23. Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF (2006) Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 7:475-483
24. Fernandez-de-las-Penas C, Penacoba-Puente C, Cigaran-Mendez M, Diaz-Rodriguez L, Rubio-Ruiz B, Arroyo-Morales M (2014) Has catechol-O-methyltransferase genotype (Val158Met) an influence on endocrine, sympathetic nervous and humoral immune systems in women with fibromyalgia syndrome? Clin J Pain 30:199-204
25. Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C et al (2007) Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 6:167-176
26. Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A et al (2013) FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenet Genomics 23:156-166
27. Lessard J, Holman EA (2014) FKBP5 and CRHR1 polymorphisms moderate the Stress-Physical Health Association in a National Sample. Health Psychol 33:1046-1056
28. Fujii T, Hori H, Ota M, Hattori K, Teraishi T, Sasayama D et al (2014) Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression. Psychoneuroendocrinology 42:89-97
29. Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM et al (2003) Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 11:7-116
30. Maes M, Hendriks D, Van Gastel A, Demedts P, Wauters A, Neels H et al (1997) Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers. Psychoneuroendocrinology 22:397-409
31. Settipane GA, Pudupakkam RK, McGowan JH (1978) Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol 62:162-166
32. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM (2006) The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol 177:2926-2938
33. Armbruster D, Mueller A, Strobel A, Lesch KP, Brocke B, Kirschbaum C (2012) Children under stress-COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm. Int J Neuropsychopharmacol 15:1229-1239
34. Walder DJ, Trotman HD, Cubells JF, Brasfield J, Tang YL, Walker EF (2010) Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents. Psychiatr Genet 20:166-170
35. Bouma EM, Riese H, Doornbos B, Ormel J, Oldehinkel AJ (2012) Genetically based reduced MAOA and COMT functioning is associated with the cortisol stress response: a replication study. Mol Psychiatry 17:119-121
36. Derijk RH (2009) Single nucleotide polymorphisms related to HPA axis reactivity. Neuro Immuno Modulation 16:340-352
37. Heffner KL (2011) Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease. Immunol Allergy Clin North Am 31:95-108
38. Miller AH, Spencer RL, Pearce BD, Pisell TL, Azrieli Y, Tanapat P et al (1998) Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. Cell Immunol 186:45-54
39. Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487-525
40. Stubelius A, Wilhelmson AS, Gogos JA, Tivesten A, Islander U, Carlsten H (2012) Sexual dimorphisms in the immune system of catechol-O-methyltransferase knockout mice. Immunobiology 217:751-760
41. Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520
42. Kim KJ, Fandy TE, Lee VH, Ann DK, Borok Z, Crandall ED (2004) Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 287:L616-L622
43. Martinez-Jauand M, Sitges C, Rodriguez V, Picornell A, Ramon M, Buskila D et al (2013) Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 17:16-27
44. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 88:277-284
45. Lao W, Fang M, Yang X (2012) FK506-binding protein 51 (FKBP5) gene polymorphism is not associated with glucocorticoid therapy outcome in patients with idiopathic thrombocytopenic purpura. Mol Med Rep 6:787-790
46. van Zuiden M, Kavelaars A, Geuze E, Olff M, Heijnen CJ (2013) Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions. Brain Behav Immun 30:12-21
47. Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C et al (2011) Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology 36:1053-1061